HCMT
HQL

Highland Capital Management (Texas)’s abrdn Life Sciences Investors HQL Stock Holding History

Highland Capital Management (Texas)’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-391
Closed -$11K – 296
2015
Q2 		$11K Buy
+391
New +$10.8K ﹤0.01% 297
2014
Q4 		– Sell
-25,275
Closed -$559K – 239
2014
Q3 		$559K Buy
+25,275
New +$549K 0.02% 204

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return

Highland Capital Management (Texas)'s HQL Position: Q3 2015 in Review

Highland Capital Management (Texas) sold out of abrdn Life Sciences Investors (HQL) in Q3 2015, closing a stake of 391 shares — an estimated $11K sold.

Highland Capital Management (Texas) first reported a position in HQL in Q3 2014 and held it in 2 quarters. The position peaked at $559K in Q3 2014. 48 funds tracked by Wall St. Rank hold HQL as of Q3 2015.

  • Highland Capital Management (Texas) reported no remaining abrdn Life Sciences Investors position as of Q3 2015 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 391 abrdn Life Sciences Investors shares in Q3 2015, an estimated $11K.
  • Highland Capital Management (Texas) first reported a position in abrdn Life Sciences Investors in Q3 2014 and held it in 2 quarters.
  • Highland Capital Management (Texas)'s abrdn Life Sciences Investors position peaked at $559K in Q3 2014.
  • 48 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2015.

Based on Highland Capital Management (Texas)'s 13F filing for Q3 2015, filed 16 Nov 2015.